Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area tyrosine kinase src'

Search results for: 'research area tyrosine kinase src'

Items 11-20 of 209

Page
per page
  1. PF-00562271
    A8320 PF-00562271
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor,potent and ATP-competitive
      insoluble in EtOH; insoluble in H2O; ≥11.1 mg/mL
  2. Cediranib (AZD217)
    A1882 Cediranib (AZD217)
    Target: VEGFR
    Summary: VEGFR inhibitor receptor,highly potent
      ≥22.52 mg/mL
  3. PHA-665752
    A2307 PHA-665752
     1 Citation
    Target: c-MET
    Summary: C-Met inhibitor,potent and ATP-competitive
  4. PF-562271 HCl
    A8345 PF-562271 HCl
    Target: FAK|Pyk2
    Summary: FAK/Pyk2 inhibitor
      ≥26.35 mg/mL
  5. R788 disodium
    A8332 R788 disodium
    Target: Syk
    Summary: Syk inhibitor,ATP competitive and potent
      ≥62.4 mg/mL
  6. NVP-AEW541
    A2278 NVP-AEW541
    Target: Insulin Receptor
    Summary: IGF-IR inhibitor, novel, potent and selective
      ≥22 mg/mL
  7. Lapatinib
    A8218 Lapatinib
     2 Citation
    Target: ErbB
    Summary: EGFR/HER2 inhibitor,potent,selective and reversible
      ≥29.05 mg/mL
  8. Regorafenib hydrochloride
    A3750 Regorafenib hydrochloride
    Target: Raf|VEGFR|PDGFR|c-Kit|c-RET
    Summary: Tyrosine kinase inhibitor
      ≥25.95 mg/mL
  9. PPY A
    A8607 PPY A
    Target: Abl kinases
    Summary: Abl kinases inhibitor
      <37.24 mg/mL
  10. Gefitinib (ZD1839)
    A8219 Gefitinib (ZD1839)
     3 Citation
    Target: EGFR
    Summary: Selective EGFR inhibitor
      ≥22.34 mg/mL

Items 11-20 of 209

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Apoptosis 7item
  2. Chromatin/Epigenetics 31item
  3. MAPK Signaling 13item
  4. Tyrosine Kinase 78item
  5. DNA Damage/DNA Repair 5item
  6. PI3K/Akt/mTOR Signaling 28item
  7. Microbiology & Virology 2item
  8. Cell Cycle/Checkpoint 45item
  9. JAK/STAT Signaling 26item
  10. TGF-β / Smad Signaling 21item
  11. GPCR/G protein 1 item
  12. Stem Cell 3item
  13. Membrane Transporter/Ion Channel 4item
  14. Cancer Biology 1 item
  15. Neuroscience 3item
  16. Other Signal Transduction 1 item
  17. Others 8item
  18. Immunology/Inflammation 1 item
Specificity
  1. Selective 129item
  2. Non-Selective 1 item
Reversibility
  1. Reversible 10item
  2. Irreversible 5item
Target
  1. Cyclin-Dependent Kinases 17item
  2. Histone Deacetylases (HDACs) 1 item
  3. Akt 3item
  4. PI3K 9item
  5. Raf 8item
  6. Aurora Kinases 16item
  7. CSF-1R 4item
  8. mTOR 6item
  9. FLT3 11item
  10. GSK-3 5item
  11. PLK 5item
  12. Chk 3item
  13. Eph Receptors 2item
  14. VEGFR 22item
  15. PDGFR 16item
  16. c-Kit 9item
  17. RET 2item
  18. IRAK 1 item
  19. Bromodomain-containing proteins(BRDs) 1 item
  20. p38 4item
  21. PKB 1 item
  22. Bcr-Abl 8item
  23. MEK 2item
  24. FGFR 8item
  25. Pim 3item
  26. Voltage-gated Sodium (NaV) Channels 1 item
  27. MET 3item
  28. Src 15item
  29. Trk Receptors 1 item
  30. STAT 3item
  31. EGFR 14item
  32. ROCK 3item
  33. FAK 2item
  34. JAK 13item
  35. Syk 3item
  36. DNA-PK 3item
  37. AMPK 1 item
  38. ErbB 4item
  39. ERK 3item
  40. c-MET 4item
  41. PKC 9item
  42. Ca2 /calmodulin-dependent protein kinases (CaMKs) 3item
  43. Lyn 1 item
  44. Pyk2 2item
  45. LRRK2 5item
  46. Insulin and Insulin-like Receptors 3item
  47. ALK 4item
  48. Sphingosine kinases (SphKs) 2item
  49. PKG 1 item
  50. PKA 3item
  51. Myosin light chain kinases (MLCKs) 1 item
  52. MK2 1 item
  53. Angiotensin-Converting Enzymes (ACEs) 1 item
  54. Tie-2 1 item
  55. RSK 2item
  56. ATM/ATR 3item
  57. Farnesyl Diphosphate Synthases 1 item
  58. CK2 3item
  59. HIPK2 1 item
  60. HIPK3 1 item
  61. P2X Receptors 1 item
  62. Histamine H1 Receptors 1 item
  63. P110 1 item
  64. Hck 2item
  65. MNK 1 item
  66. 5-Lipoxygenases 1 item
  67. Insulin Receptors 1 item
  68. IRG-1R 1 item
  69. eEF-2 1 item
  70. Cdc7 1 item
  71. ZAP-70 1 item
  72. c-RET 3item
  73. p70 rsk 2item
  74. VEGFR3/FLT4 1 item
  75. NTRK1/TRKA 1 item
  76. CSF-1R/c-Fms 1 item
  77. TAM kinase 1 item
  78. KDR 1 item
  79. Fyn kinase 1 item
  80. Abl kinases 1 item
  81. AXL 1 item
  82. c-Fms tyrosine kinase 1 item
  83. insulin 1 item
  84. STK 1 item
  85. MSK 1 item
  86. Lyn kinase 1 item
  87. Mer tyrosine kinase 1 item
  88. ErbB-2 1 item
  89. PDK-1 1 item
  90. Histone Acetyltransferases (HATs) 1 item
  91. Prk 1 item
  92. ITK 1 item
  93. NUAK 1 item
  94. DCLK2 1 item
  95. PTK 1 item
  96. phosphatidylinositol kinase 1 item
  97. Lck 1 item
  98. Flk1 2item
  99. Protein Tyrosine Phosphatases 1 item
  100. alkaline phosphatases 1 item
  101. ATPases 1 item
  102. glutamate release 1 item
  103. FGR 1 item
  104. YES 2item
  105. Fyn 2item
  106. ARG 1 item
  107. TRPC channel 1 item
  108. PKD 1 item
  109. enoyl-acyl-carrier protein reductase 1 item
  110. Rho-kinase 1 item
  111. tropomyosin receptor kinase 1 item
  112. SK 1 item
  113. PPK 1 item
  114. c-Syk 1 item
  115. CDK1/CyclinB 1 item
  116. PIM1 kinase 1 item
  117. phospholipase A2 1 item
  118. PIKfyve 1 item
  119. Insulin Receptor 1 item
Related Disease
  1. Acute Myeloid Leukemia 10item
  2. Adrenocortical Carcinoma 2item
  3. Bladder Cancer 2item
  4. Bladder Carcinoma 1 item
  5. B-lymphoid Malignancies 1 item
  6. Breast Cancer 22item
  7. Cancer 124item
  8. Cervical Cancer 3item
  9. Cholangiocarcinoma 1 item
  10. Chronic Lymphocytic Leukemia 1 item
  11. Clear Cell Renal Cell Carcinoma 1 item
  12. Colon Cancer 10item
  13. Colon Carcinoma 1 item
  14. Colorectal Cancer 13item
  15. Glioblastoma 10item
  16. Glioma 4item
  17. Hepatocellular Carcinoma 3item
  18. HIV Infections 1 item
  19. Leukemia 6item
  20. Liver Cancer 2item
  21. Lung Cancer 5item
  22. Lung Carcinoma 1 item
  23. Lymphoma 7item
  24. Mantle Cell Lymphoma 1 item
  25. Melanoma 7item
  26. Multiple Myeloma 3item
  27. Myelofibrosis 1 item
  28. Non-small Cell Lung Cancer 4item
  29. Ovarian Cancer 9item
  30. Pancreatic Cancer 13item
  31. Prostate Cancer 7item
  32. Psoriasis 1 item
  33. Renal Cancer 2item
  34. Renal Cell Carcinoma 2item
  35. Rheumatoid Arthritis 4item
  36. Thyroid Cancer 3item
  37. Type 2 Diabetes 1 item